Stephen B. Baylin

177.9k citations

444 papers · 77.0k indexed · 29 hit papers · h-index 131

Impact in

Cancer Research top 0.01%
- Cancer Genomics and Diagnostics
Molecular Biology top 0.01%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
- Genomics and Chromatin Dynamics

Papers in

Molecular Biology 346
- Epigenetics and DNA Methylation 246
- Cancer-related gene regulation 131
- RNA modifications and cancer 81
- Histone Deacetylase Inhibitors Research 47
- Genomics and Chromatin Dynamics 38
- Polyamine Metabolism and Applications 34
Cancer Research 65
- Cancer Genomics and Diagnostics 37

Co-authors: James G. Herman Peter A. Jones Jean‐Pierre J. Issa Manel Esteller Joyce E. Ohm Nita Ahuja Edward Gabrielson David Sidransky
Journals: Cancer Research (44 papers)Proceedings of the National Academy of Sciences (24 papers)Oncogene (13 papers)Clinical Cancer Research (12 papers)Cancer Cell (9 papers)
Partner nations: United States Belgium Netherlands

In The Last Decade

Stephen B. Baylin

442 papers receiving 75.2k citations

Hit Papers

15 papers align trajectories log scale

Epigenetic Determinants of Cancer 2016 · 860 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Cold Spring Harbor Perspectives in Biology
2016 Nature Reviews Genetics
2011 Nature reviews. Cancer
2007 Nature Genetics
2007 Cell
2006 Nature reviews. Cancer
2006 PLoS Medicine
2005 Cell
2005 Nature Clinical Practice Oncology
2004 Nature Genetics
2003 New England Journal of Medicine
2003 Nature
2002 Nature Genetics
2002 Nature Reviews Genetics
2002 Nature
2001 PubMed
2001 Human Molecular Genetics
2000 New England Journal of Medicine
2000 PubMed
2000 Trends in Genetics
1999 PubMed
1999 Proceedings of the National Academy of Sciences
1998 Proceedings of the National Academy of Sciences
1998 Proceedings of the National Academy of Sciences
1998 PubMed
1995 PubMed
1995 Nature Medicine
1995 PubMed
1994 Nature Genetics

Peers

Countries citing papers authored by Stephen B. Baylin

Since Specialization

Citations

This map shows the geographic impact of Stephen B. Baylin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen B. Baylin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen B. Baylin more than expected).

Fields of papers citing papers by Stephen B. Baylin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen B. Baylin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen B. Baylin. The network helps show where Stephen B. Baylin may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen B. Baylin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen B. Baylin Line = papers co-authored together Stephen B. Baylin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Epigenetic Therapies in Ovarian Cancer Alter Repetitive Element Expression in a TP53 -Dependent Manner Cancer Research ·James I. McDonald, Noor Diab, Elisa Arthofer, Melissa Hadley, Tomas Kanholm, Uzma Rentia, Stephanie Gomez, Angela Yu, Erin E. Grundy, Olivia L. Cox, Michael J. Topper, Xiaoyun Xing, Pamela L. Strissel, Reiner Strick, Ting Wang, Stephen B. Baylin, Katherine B. Chiappinelli	2021	23
2	DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer Cancer Research ·Meghan Travers, Stephen M. Brown, Matthew Dunworth, Cassandra E. Holbert, Karla R. Wiehagen, Kurtis E. Bachman, Jackson R. Foley, Meredith L. Stone, Stephen B. Baylin, Robert A. Casero, Cynthia A. Zahnow	2019	82
3	A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine Cancer Research ·Benjamin R. Leadem, Ioannis Kagiampakis, Catherine Wilson, Tommy K. Cheung, David Arnott, Patrick Trojer, Marie Classon, Hariharan Easwaran, Stephen B. Baylin	2017	37
4	Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum Clinical Cancer Research ·Alicia Hulbert, Ignacio Jusué-Torres, Alejandro Stark, Chen Chen, Kristen Rodgers, Beverly Lee, Candace Griffin, Andrew Yang, Peng Huang, John Wrangle, Steven A. Belinsky, Tza‐Huei Wang, Stephen C. Yang, Stephen B. Baylin, Malcolm V. Brock, James G. Herman	2016	198
5	Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood Cancer Prevention Research ·Veerle Melotte, Joo Mi Yi, Marjolein H.F.M. Lentjes, Kim M. Smits, Leander Van Neste, Hanneke E.C. Niessen, Kristien Wouters, Joost Louwagie, Kornel E. Schuebel, James G. Herman, Stephen B. Baylin, Wim Van Criekinge, Gerrit A. Meijer, Nita Ahuja, Manon van Engeland	2014	31
6	Functional Identification of Cancer-Specific Methylation of CDO1 , HOXA9 , and TAC1 for the Diagnosis of Lung Cancer Clinical Cancer Research ·John Wrangle, Emi Ota Machida, Ludmila Danilova, Alicia Hulbert, Noreli Franco, Wei Zhang, Sabine C. Glöckner, Mathewos Tessema, Leander Van Neste, Hariharan Easwaran, Kornel E. Schuebel, Julien Licchesi, Craig M. Hooker, Nita Ahuja, Jun Amano, Steven A. Belinsky, Stephen B. Baylin, James G. Herman, Malcolm V. Brock	2014	65
7	Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines Clinical Cancer Research ·Jana Jeschke, Heather M. O’Hagan, Wei Zhang, Rajita Vatapalli, Marília Freitas Calmon, Ludmila Danilova, Claudia Nelkenbrecher, Leander Van Neste, Ingrid T.G.W. Bijsmans, Manon van Engeland, Edward Gabrielson, Kornel E. Schuebel, Andreas Winterpacht, Stephen B. Baylin, James G. Herman, Nita Ahuja	2013	68
8	Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer Clinical Cancer Research ·Joo Mi Yi, Angela A. Guzzetta, Vasudev J. Bailey, Stephanie R. Downing, Leander Van Neste, Katherine B. Chiappinelli, Brian P. Keeley, Alejandro Stark, Alexander Herrera, Christopher L. Wolfgang, Emmanouil P. Pappou, Christine A. Iacobuzio–Donahue, Michael Goggins, James G. Herman, Tza‐Huei Wang, Stephen B. Baylin, Nita Ahuja	2013	118
9	CpG Island Methylator Phenotype–Positive Tumors in the Absence of MLH1 Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis Clinical Cancer Research ·Tao Fu, Emmanouil P. Pappou, Angela A. Guzzetta, Jana Jeschke, Ruby Kwak, Pujan Dave, Craig M. Hooker, Richard A. Morgan, Stephen B. Baylin, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Nita Ahuja	2012	41
10	Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer Clinical Cancer Research ·Joo Mi Yi, Mashaal Dhir, Leander Van Neste, Stephanie R. Downing, Jana Jeschke, Sabine C. Glöckner, Marília Freitas Calmon, Craig M. Hooker, Juan M. Funes, Chris Boshoff, Kim M. Smits, Manon van Engeland, Matty P. Weijenberg, Christine A. Iacobuzio–Donahue, James G. Herman, Kornel E. Schuebel, Stephen B. Baylin, Nita Ahuja	2011	118
11	Combination Therapy with Vidaza and Entinostat Suppresses Tumor Growth and Reprograms the Epigenome in an Orthotopic Lung Cancer Model Cancer Research ·Steven A. Belinsky, Marcie J. Grimes, Maria A. Picchi, Hugh Mitchell, Chris A. Stidley, Yohannes Tesfaigzi, Meghan M. Channell, Yanbin Liu, Robert A. Casero, Stephen B. Baylin, Mathew D. Reed, Carmen S. Tellez, Thomas H. March	2011	56
12	Aberrant Silencing of Cancer-Related Genes by CpG Hypermethylation Occurs Independently of Their Spatial Organization in the Nucleus Cancer Research ·Hariharan Easwaran, Leander Van Neste, Leslie Cope, Subhojit Sen, Helai P. Mohammad, Gayle J. Pageau, Jeanne B. Lawrence, James G. Herman, Kornel E. Schuebel, Stephen B. Baylin	2010	23
13	Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes Clinical Cancer Research ·Yi Huang, Tracy Murray Stewart, Yu Wu, Stephen B. Baylin, Laurence J. Marton, Brandy Perkins, Richard J. Jones, Patrick M. Woster, Robert A. Casero	2009	158
14	Polycomb CBX7 Promotes Initiation of Heritable Repression of Genes Frequently Silenced with Cancer-Specific DNA Hypermethylation Cancer Research ·Helai P. Mohammad, Yi Cai, Kelly M. McGarvey, Hariharan Easwaran, Leander Van Neste, Joyce E. Ohm, Heather M. O’Hagan, Stephen B. Baylin	2009	61
15	Defining a Chromatin Pattern that Characterizes DNA-Hypermethylated Genes in Colon Cancer Cells Cancer Research ·Kelly M. McGarvey, Leander Van Neste, Leslie Cope, Joyce E. Ohm, James G. Herman, Wim Van Criekinge, Kornel E. Schuebel, Stephen B. Baylin	2008	94
16	Promoter Methylation of Genes in and around the Candidate Lung Cancer Susceptibility Locus 6q23-25 Cancer Research ·Mathewos Tessema, Randy Willink, Kieu Do, Yang Yu, Wayne Yu, Emi Ota Machida, Malcolm V. Brock, Leander Van Neste, Christine A. Stidley, Stephen B. Baylin, Steven A. Belinsky	2008	91
17	A Requirement for DICER to Maintain Full Promoter CpG Island Hypermethylation in Human Cancer Cells Cancer Research ·Angela H. Ting, Hiromu Suzuki, Leslie Cope, Kornel E. Schuebel, Byron Lee, Minoru Toyota, Kohzoh Imai, Yasuhisa Shinomura, Takashi Tokino, Stephen B. Baylin	2008	41
18	DNA Methylation and Complete Transcriptional Silencing of Cancer Genes Persist after Depletion of EZH2 Cancer Research ·Kelly M. McGarvey, Eriko Greene, Jill A. Fahrner, Thomas Jenuwein, Stephen B. Baylin	2007	87
19	hTERT Is Expressed in Cancer Cell Lines Despite Promoter DNA Methylation by Preservation of Unmethylated DNA and Active Chromatin around the Transcription Start Site Cancer Research ·Rebekah L. Zinn, Kevin Pruitt, Sayaka Eguchi, Stephen B. Baylin, James G. Herman	2007	163
20	Hypermethylation of ASC/TMS1 Is a Sputum Marker for Late-Stage Lung Cancer Cancer Research ·Emi Ota Machida, Malcolm V. Brock, Craig M. Hooker, Jun Nakayama, Akiko Ishida, Jun Amano, Maria A. Picchi, Steven A. Belinsky, James G. Herman, Shun’ichiro Taniguchi, Stephen B. Baylin	2006	77

About Stephen B. Baylin

Stephen B. Baylin is a scholar working on Molecular Biology, Cancer Research, Oncology, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 444 papers that have together received 77.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (246 papers), Cancer-related gene regulation (131 papers), RNA modifications and cancer (81 papers), Histone Deacetylase Inhibitors Research (47 papers), Genomics and Chromatin Dynamics (38 papers), Cancer Genomics and Diagnostics (37 papers), Polyamine Metabolism and Applications (34 papers) and Neuroendocrine Tumor Research Advances (30 papers). The work is most often cited by research in Cancer Research (13.8k citations), Molecular Biology (60.4k citations), Oncology (16.0k citations), Pathology and Forensic Medicine (7.6k citations) and Genetics (8.8k citations). Stephen B. Baylin has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include James G. Herman, Peter A. Jones, Jean‐Pierre J. Issa, Manel Esteller, Joyce E. Ohm, Nita Ahuja, Edward Gabrielson, David Sidransky, Nancy E. Davidson and Adrian Merlo. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, Oncogene, Clinical Cancer Research and Cancer Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact